News about hearing aids, hearing loss, cochlear implants, and more
Page 21 of 35
)
Artificial intelligence (AI) and deep neural networks (DNN) are transforming how hearing aids perform in noise, quiet, and for healthcare applications. HearingTracker interviews Whisper AI audio engineer Andreas Thelander Bertelsen about where AI and DNN are taking hearing aids.
)
Results of a randomized clinical effectiveness trial published in a prestigious medical journal found that a do-it-yourself programming app worked well for users of over-the-counter (OTC) hearing aids.
)
CI2023 Cochlear Implants in Children and Adults will feature the (Re)Habilitation Connect Forum on June 9 at the Hyatt Regency Dallas Hotel in Dallas, Texas. The Forum will emphasize clinically applicable, research-based information, and attendees will Continue the Conversation at a reception.
)
Costco is now offering the Lexie B2 over-the-counter (OTC) hearing aid on its website for $980—the first OTC hearing aid to be offered by the mass merchandiser.
)
Knowles announces the release the first-of-its-kind Digital Voice Vibration Sensor, V2S200D, a high bandwidth, low-power specialized vibration sensor that improves voice call quality in noisy environments by picking up the speaker’s voice and rejecting ambient sounds.
)
The new Phonak Slim Lumity hearing aid features a sleek new design with unique left and right fittings that follow the natural contour of the head and comes in four unique versions with two-tone color.
)
Google will be teaming up with the National Acoustic Laboratories (NAL), Cochlear, Macquarie University Hearing, NextSense, and The Shepherd Center to explore new ideas for applying artificial intelligence (AI) and machine learning to challenges in listening and communication for people with hearing loss.
)
Using a new computational approach, researchers at the Icahn School of Medicine at Mount Sinai and colleagues analyzed large genetic datasets from rare disease cohorts and discovered previously unknown genetic causes of three rare conditions: primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness.
)
Neuromod Devices Ltd. announced today that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire, the first bimodal neuromodulation device of its kind to be approved by the FDA for the treatment of tinnitus.
)
HearingTracker interviews Oticon President Gary Rosenblum about the company's newest flagship hearing aid, Oticon Real, as well as BrainHearing, DNN, and the Polaris R platform that drives technology in the new device.
)
On World Hearing Day, the Hear Well campaign is premiering the “Take 3 For Me Hearing Challenge,” an online hearing screening adapted from the Hearing Handicap Inventory-Screening Version (HHIE-S) with input and review by audiologists.
)
Starkey Hearing Technologies believes its new Genesis AI hearing aid—and the chip platform powering it—will define AI-assisted hearing healthcare for years to come. Here are highlights of the new device and a summary of the company's launch event at Starkey headquarters in Minneapolis.
)
)
